CIK: 1206466 - Address: C/o Bioheart, Inc., 13794 Nw 4Th Street, Suite 212, Sunrise, FL 33325
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret118-1-2-132432015
S%wins75637513131342

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/22/04 15:48
10/31/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS.a-711.1010-10556D175154745561322-6-75-12-25-24
11/17/03 15:40
11/13/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS.m-24410.894-22-3636M246467109134-18-3-6-5314738
11/10/03 15:54
11/6/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS.m-9711.305-9-1658D236762105294-3-1-51-3365333
11/6/03 14:37
11/4/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS.m-9011.215-8-1667M306866101332522-5-2345127
11/4/03 16:31
10/31/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS-9711.256-9-1675M44836410128-33-20-60375724
11/3/03 18:37
10/30/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS-8011.416-7-1684M3786619727-8110-12405520
10/31/03 15:06
10/29/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS-6611.006-6-1691D3583738925214-13-2415323
10/29/03 15:54
10/27/03
NABINabi BiopharmaceuticalsDEHealthBioPrdBiological Products, (No DiagGury David JFLDS.m-11910.826-11-2699D359575831872153-1495321

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact